ULO
TM 202303801 (326535)
Key information
Application number 202303801 Trademark text ULO Case type National mark Status - 28.04.2023 Uten forutgående uttalelse
Filed 17.03.2023 Registration number 326535 Registered 28.04.2023 Published in the Gazette 08.05.2023 Opposition deadline 08.08.2023 Grace period start date, cf. Trademarks Act Section 37 09.08.2023 Renewal deadline 17.03.2033 Trademark category Trademark Type of Mark Word Mark Goods/services (NICE class) 5 Acquired distinctiveness No Applicant Sunovion Pharmaceuticals Inc. (US) Owner Sunovion Pharmaceuticals Inc. (US) Agent ACAPO ONSAGERS AS (NO)
List of products
Class 5 Farmasøytiske preparater for behandling av sykdommer og lidelser i sentralnervesystemet; farmasøytiske preparater for behandling av schizofreni; farmasøytiske preparater for behandling av kognitive lidelser.
Documents
Date
| 15.05.2023 | 05-01 | Saksbehandling | 202303801 | UT | Oversendelse reg. brev (VM202303801) | ACAPO AS | ||
| 12.05.2023 | 04-01 | Saksbehandling | 202303801(326535) | INN | Korrespondanse (Hovedbrev inn) | ACAPO AS | ||
| 28.04.2023 | 03-01 | Saksbehandling | 202303801 | UT | Oversendelse reg. brev (VM202303801) | ACAPO AS | ||
| 28.03.2023 | 02-02 | Saksbehandling | 202303801 | INN | Fullmakt - ULO (Sunovion Pharmaceuticals Inc.) | ACAPO AS | ||
| 28.03.2023 | 02-01 | Saksbehandling | 202303801 | INN | Korrespondanse (Hovedbrev inn) | ACAPO AS | ||
| 17.03.2023 | 01-01 | Saksbehandling | 202303801 | INN | Søknadsskjema Varemerke | ACAPO AS |